UnknownNot Applicable

Efficacy of Neuromuscular Training and Manual Therapy With Augmented Low-Dye Taping Technique for Correction of Pronated Foot in the Management of Anterior Knee Pain

United Arab Emirates60 participantsStarted 2023-06-15

Plain-language summary

The goal of this clinical trial\] is to To find out the effect of Neuromuscular Training and Manual therapy with Augmented Low - Dye Taping technique for correction of Pronated foot in the management of Anterior knee pain patients. The main question\[s\] it aims to answer are: * Is there any Kinematic association of biomechanical risk factors between anterior knee pain \& pronated foot? * Is there any potential impact of therapeutic foot interventions for correction of Pronated foot in the management of anterior knee pain?

Who can participate

Age range

18 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age - 18 to 35 years * Sex - both males \& females * Clinically diagnosed patient of PFPS with Pronated foot * Anterior or posterior pain in the knee area lasting for more than 12 weeks * Excessive calcaneal eversion measured at 6° in the relaxed posture * Score of between three and seven points on the numerical pain rating in activities of daily living Kujala Scale Point 40 \& Above Exclusion Criteria: * A history of diagnosis of meniscus or joint injury \& knee joint surgery * Taking nonsteroidal anti-inflammatory drugs or corticosteroids within 24 hrs before the test * History of brain injury or vestibular disorder within the last 6 months * Positive sign of Patellar Apprehension test * Congenital or traumatic deformity * Allergic reactions to taping * Concomitant diagnosis of pre patellar bursitis or tendonitis * knee Ligamentous injury or laxity * Plica syndrome \& Osgood Schlatter's disease * Malignancy \& Skin Infection * Pregnant woman or lactating women.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

AKPS (Kujala Scale)

Timeframe: 6 months

FPI

Timeframe: 6 months

NPRS

Timeframe: 6 months

DVI

Timeframe: 6 months

Trial details

NCT IDNCT05917080

SponsorMediclinic Al Noor Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

Contact for this trial

Albert Anand.U, MPT

971 501224393 albertmpt@gmail.com

View on ClinicalTrials.gov More Anterior Knee Pain Syndrome trials

Plain-language summary

Who can participate

Age range

18 Years – 35 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.